Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Oncologix Tech Inc. (OCLG) had Revenue of $1.24M for the most recently reported fiscal quarter, ending 2015-05-31.

Quarterly Annual

Figures for fiscal quarter ending 2015-05-31

Income Statement Financials
Revenue	$1.24M
Net Income	$-0.53M
Cost of Goods Sold	$0.89M
Gross Profit	$0.35M
Operating Expenses	$1.33M
Operating Income	$-0.10M
Non-Operating Income/Expense	$-0.43M
Pre-Tax Income	$-0.53M
Normalized Pre-Tax Income	$-0.53M
Income after Taxes	$-0.53M
Income from Continuous Operations	$-0.53M
Consolidated Net Income/Loss	$-0.53M
Normalized Income after Taxes	$-0.53M
EBIT	$-0.10M
EBITDA	$0.06M
Weighted-Average Shares Outstanding (Basic)	242.59M
Weighted-Average Shares Outstanding (Diluted)	242.59M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$1.31M
Property, Plant, and Equipment	$0.04M
Long-Term Assets	$2.54M
Total Assets	$3.85M
Current Liabilities	$4.67M
Long-Term Debt	$0.38M
Long-Term Liabilities	$0.38M
Total Liabilities	$5.04M
Common Equity	$-1.19M
Tangible Shareholders Equity	$-3.61M
Shareholders Equity	$-1.19M
Common Shares Outstanding	276.75M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.39M
Cash Flow from Investing Activities	$-0.56M
Cash Flow from Financial Activities	$1.06M
Beginning Cash	$0.02M
End Cash	$0.12M
Increase/Decrease in Cash	$0.10M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.28
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.46
Debt to Equity Ratio	-2.80
Gross Margin	28.33%
Operating Margin	-8.00%
EBIT Margin	-8.00%
EBITDA Margin	--
Pre-Tax Profit Margin	-42.52%
Profit Margin	-42.52%
Free Cash Flow	$-0.39M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.32
Inventory Turnover	6.44
Receiveable Turnover	1.19
Days Sales in Receivables	75.53
Return on Equity	44.19%
Return on Tangible Equity	14.54%
Return on Assets	-13.64%
Return on Investments	64.64%
Book Value Per Share	$-0.00
Free Cash Flow per Share	$-0.00
Operating Cash Flow per Share	$-0.00

Data from Zacks Investment Research, Inc.